Characterization of tau proteins in human neuroblastoma SH-SY5Y cell line.
Here we report three experimental paradigms in which tau proteins are differentially localized and expressed in human neuroblastoma cells SH-SY5Y. We found that in undifferentiated cells, tau proteins were predominantly localized in the nucleus. Western blot analysis of nuclear extracts revealed, among the others, a high molecular weight tau isoform and evaluation of tau mRNA levels showed a single tau isoform. After differentiation, tau immunoreactivity was detected only in cytosol and along neuritic processes. The high molecular weight tau isoform disappeared and an additional tau mRNA species was detected. Treatment of differentiated cells with doxorubicin or okadaic acid resulted in an increase of tau immunoreactivity and in a subsequent cell loss. Our results indicate that both subcellular localization and pattern of expression of tau proteins vary depending on the developmental and functional state of the cells, thus suggesting different roles in cell function.
Uberti
D
D
Department of Biomedical Sciences and Biotechnologies, Brescia University School of Medicine, Italy.
Rizzini
C
C
Spano
P F
PF
Memo
M
M
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D016923:Cell Death / Q000187:drug effects; D002454:Cell Differentiation / Q000502:physiology; D004317:Doxorubicin / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D007150:Immunohistochemistry; D009447:Neuroblastoma; D009474:Neurons / Q000737:chemistry*; D019319:Okadaic Acid / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D016875:tau Proteins / Q000032:analysis*
D000903:Antibiotics, Antineoplastic; D004791:Enzyme Inhibitors; D016875:tau Proteins; D019319:Okadaic Acid; D004317:Doxorubicin